Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
about
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice.Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan.Exploring factors predicting changes in patients' expectations and psychosocial issues during the course of treatment with intravitreal injections for wet age-related macular degeneration.
P2860
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
@en
type
label
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
@en
prefLabel
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
@en
P2860
P1433
P1476
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.
@en
P2093
Carolyn K Hulme-Lowe
Jordana K Schmier
P2860
P2888
P304
P356
10.1007/S40273-015-0347-Y
P577
2015-11-12T00:00:00Z